Cell-cell interaction between vocal fold fibroblasts and bone marrow mesenchymal stromal cells in three-dimensional hyaluronan hydrogel

Journal of Tissue Engineering and Regenerative Medicine

Volumn 10, Issue 5, 2016, Pages 437-446

  Chen, Xia ^a   Thibeault, Susan L ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

BM MSCs; Cell regulation; Hydrogel; Three dimensional co culture; VFFs

Indexed keywords

BONE; CELL ENGINEERING; CELL PROLIFERATION; ENDOTHELIAL CELLS; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLASTS; FLOWCHARTING; GENE EXPRESSION; HYALURONIC ACID; HYDROGELS; SPEECH; TISSUE REGENERATION;

BONE MARROW; BONE MARROW-DERIVED MSC; CELL REGULATION; CO-CULTURES; HYALURONAN HYDROGELS; MESENCHYMAL STROMAL CELLS; SURVIVAL RATE; THREE-DIMENSIONAL CO-CULTURE; VOCAL FOLD FIBROBLAST; VOCAL FOLDS;

CELL CULTURE;

COLLAGEN TYPE 1; HYALURONIC ACID; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; SCATTER FACTOR; VASCULOTROPIN; CYTOKINE; MMP1 PROTEIN, HUMAN;

ARTICLE; CELL INTERACTION; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HYDROGEL; MESENCHYMAL STROMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TISSUE REGENERATION; BONE MARROW CELL; CELL COMMUNICATION; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; METABOLISM; PHARMACOLOGY; VOCAL CORD;

BONE MARROW CELLS; CELL COMMUNICATION; CYTOKINES; EXTRACELLULAR MATRIX; FIBROBLASTS; HUMANS; HYALURONIC ACID; HYDROGELS; MATRIX METALLOPROTEINASE 1; MESENCHYMAL STROMAL CELLS; VOCAL CORDS;

EID: 84877116820     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1757     Document Type: Article

References (54)

1. Benninger MS, Alessi D, Archer S et al. 1996; Vocal fold scarring: current concepts and management. Otolaryngol Head Neck Surg 115: 474-482.
2. Bless DM, Welham NV. 2010; Characterization of vocal fold scar formation, prophylaxis, and treatment using animal models. Curr Opin Otolaryngol Head Neck Surg 18: 481-486.
3. Caplan AI. 2010; What's in a name?. Tissue Eng Part A 16: 2415-2417.
4. Chen X, Thibeault SL. 2008; Characteristics of age-related changes in cultured human vocal fold fibroblasts. Laryngoscope 118: 1700-1704.
5. Chen X, Thibeault SL. 2010a; Biocompatibility of a synthetic extracellular matrix on immortalized vocal fold fibroblasts in 3D culture. Acta Biomater 6: 2940-2948.
6. Chen X, Thibeault SL. 2010b; Role of tumor necrosis factor-α in wound repair in human vocal fold fibroblasts. Laryngoscope 120: 1819-1825.
7. Crouch SP, Kozlowski R, Slater KJ et al. 1993; The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J Immunol Methods 160: 81-88.
8. Doganci A, Sauer K, Karwot R et al. 2005; Pathological role of IL-6 in the experimental allergic bronchial asthma in mice. Clin Rev Allergy Immunol 28: 257-270.
9. Donnelly JJ, Xi MS, Rockey JH. 1993; A soluble product of human corneal fibroblasts inhibits lymphocyte activation. Enhancement by interferon-γ. Exp Eye Res 56: 157-165.
10. Duflo S, Thibeault SL, Li W et al. 2006a; Effect of a synthetic extracellular matrix on vocal fold lamina propria gene expression in early wound healing. Tissue Eng 12: 3201-3207.
11. Duflo S, Thibeault SL, Li W et al. 2006b; Vocal fold tissue repair in vivo using a synthetic extracellular matrix. Tissue Eng 12: 2171-2180.
12. Francois S, Bensidhoum M, Mouiseddine M et al. 2006; Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution after irradiation damage. Stem Cells 24: 1020-1029.
13. Gray SD, Titze IR, Alipour F et al. 2000; Biomechanical and histologic observations of vocal fold fibrous proteins. Ann Otol Rhinol Laryngol 109: 77-85.
14. Halum SL, Naidu M, Delo DM et al. 2007; Injection of autologous muscle stem cells (myoblasts) for the treatment of vocal fold paralysis: a pilot study. Laryngoscope 117: 917-922.
15. Haniffa MA, Collin MP, Buckley CD et al. 2009; Mesenchymal stem cells: the fibroblasts' new clothes? Haematologica 94: 258-263.
16. Hansen JK, Thibeault SL. 2006; Current understanding and review of the literature: vocal fold scarring. J Voice 20: 110-120.
17. Hanson SE, Kim J, Johnson BH et al. 2010; Characterization of mesenchymal stem cells from human vocal fold fibroblasts. Laryngoscope 120: 546-551.
18. Hirano M. 1995; Phonosurgery: past, present, future. Chevalier Jackson Lecture: 25-30.
19. Hirano S, Bless D, Heisey D et al. 2003; Roles of hepatocyte growth factor and transforming growth factor-β1 in production of extracellular matrix by canine vocal fold fibroblasts. Laryngoscope 113: 144-148.
20. Hirano S, Bless DM, Rousseau B et al. 2004; Prevention of vocal fold scarring by topical injection of hepatocyte growth factor in a rabbit model. Laryngoscope 114: 548-556.
21. Hirano S, Minamiguchi S, Yamashita M et al. 2009; Histologic characterization of human scarred vocal folds. J Voice 23: 399-407.
22. Hollinger JO, Hart CE, Hirsch SN et al. 2008; Recombinant human platelet-derived growth factor: biology and clinical applications. J Bone Joint Surg Am 90(suppl 1): 48-54.
23. Hong SJ, Lee SH, Jin SM et al. 2011; Vocal fold wound healing after injection of human adipose-derived stem cells in a rabbit model. Acta Otolaryngol 131: 1198-1204.
24. Jette ME, Hayer SD, Thibeault SL. 2013; Characterization of human vocal fold fibroblasts derived from chronic scar. Laryngoscope 123: 738-745.
25. Kopp J, Preis E, Said H et al. 2005; Abrogation of transforming growth factor-β signaling by SMAD7 inhibits collagen gel contraction of human dermal fibroblasts. J Biol Chem 280: 21570-21576.
26. Korn JH. 1981; Modulation of lymphocyte mitogen responses by cocultured fibroblasts. Cell Immunol 63: 374-384.
27. Krampera M, Glennie S, Dyson J et al. 2003; Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101: 3722-3729.
28. Kumai Y, Kobler JB, Park H et al. 2010; Modulation of vocal fold scar fibroblasts by adipose-derived stem/stromal cells. Laryngoscope 120: 330-337.
29. Langston JW. 2005; The promise of stem cells in Parkinson disease. J Clin Invest 115: 23-25.
30. Le JM, Vilcek J. 1987; Accessory function of human fibroblasts in mitogen-stimulated interferon-γ production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor. J Immunol 139: 3330-3337.
31. Lichtenfels R, Biddison WE, Schulz H et al. 1994; CARE-LASS (calcein-release assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. J Immunol Methods 172: 227-239.
32. Linker-Israeli M, Deans RJ, Wallace DJ et al. 1991; Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 147: 117-123.
33. Ma EP, Yiu EM. 2001; Voice activity and participation profile: assessing the impact of voice disorders on daily activities. J Speech Lang Hear Res 44: 511-524.
34. Matsumoto K, Nakamura T. 1997; Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun 239: 639-644.
35. Mazo M, Arana M, Pelacho B et al. 2012; Mesenchymal stem cells and cardiovascular disease: a bench to bedside roadmap. Stem Cells Int 2012: Article ID 175979, 11. doi:10.1155/2012/175979.
36. Nishimoto N. 2006; Interleukin-6 in rheumatoid arthritis. Curr Opin Rheumatol 18: 277-281.
37. Ohnishi S, Sumiyoshi H, Kitamura S et al. 2007a; Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions. FEBS Lett 581: 3961-3966.
38. Ohnishi S, Yasuda T, Kitamura S et al. 2007b; Effect of hypoxia on gene expression of bone marrow-derived mesenchymal stem cells and mononuclear cells. Stem Cells 25: 1166-1177.
39. Ohno S, Hirano S, Kanemaru S et al. 2011; Implantation of an atelocollagen sponge with autologous bone marrow-derived mesenchymal stromal cells for treatment of vocal fold scarring in a canine model. Ann Otol Rhinol Laryngol 120: 401-408.
40. Proksch S, Steinberg T, Stampf S et al. 2012; Crosstalk on cell behavior in interactive cocultures of hMSCs with various oral cell types. Tissue Eng Part A 18: 2601-2610.
41. Qian L, Shim W, Gu Y et al. 2012; Hemodynamic contribution of stem cell scaffolding in acute injured myocardium. Tissue Eng Part A 18: 1652-1663.
42. Saito F, Tasaka S, Inoue K et al. 2008; Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice. Am J Respir Cell Mol Biol 38: 566-571.
43. Sarkhosh K, Tredget EE, Li Y et al. 2003; Proliferation of peripheral blood mononuclear cells is suppressed by the indoleamine 2, 3-dioxygenase expression of interferon-γ-treated skin cells in a co-culture system. Wound Repair Regen 11: 337-345.
44. Semino CE, Merok JR, Crane GG et al. 2003; Functional differentiation of hepatocyte-like spheroid structures from putative liver progenitor cells in three-dimensional peptide scaffolds. Differentiation 71: 262-270.
45. Serban MA, Liu Y, Prestwich GD. 2008; Effects of extracellular matrix analogues on primary human fibroblast behavior. Acta Biomater 4: 67-75.
46. Shimabukuro Y, Murakami S, Okada H. 1992; Interferon-γ-dependent immunosuppressive effects of human gingival fibroblasts. Immunology 76: 344-347.
47. Shu XZ, Liu Y, Palumbo F et al. 2003; Disulfide-crosslinked hyaluronan-gelatin hydrogel films: a covalent mimic of the extracellular matrix for in vitro cell growth. Biomaterials 24: 3825-3834.
48. Song R, Bian HN, Lai W et al. 2011; Normal skin and hypertrophic scar fibroblasts differentially regulate collagen and fibronectin expression as well as mitochondrial membrane potential in response to basic fibroblast growth factor. Braz J Med Biol Res 44: 402-410.
49. Svensson B, Nagubothu SR, Cedervall J et al. 2011; Injection of human mesenchymal stem cells improves healing of vocal folds after scar excision - a xenograft analysis. Laryngoscope 121: 2185-2190.
50. Thibeault SL, Klemuk SA, Chen X et al. 2010; In vivo engineering of the vocal fold ECM with injectable HA hydrogels - late effects on tissue repair and biomechanics in a rabbit model. J Voice 25: 249-253.
51. Ueki T, Kaneda Y, Tsutsui H et al. 1999; Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 5: 226-230.
52. Wolfram D, Tzankov A, Pulzl P et al. 2009; Hypertrophic scars and keloids - a review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg 35: 171-181.
53. Xu X, Xu Z, Xu Y et al. 2005; Effects of mesenchymal stem cell transplantation on extracellular matrix after myocardial infarction in rats. Coron Artery Dis 16: 245-255.
54. Xue F, Takahara T, Yata Y et al. 2003; Hepatocyte growth factor gene therapy accelerates regeneration in cirrhotic mouse livers after hepatectomy. Gut 52: 694-700.